Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Appraising the Potential Uses and Harms of LLMs for Medical Systematic Reviews
9
Zitationen
4
Autoren
2023
Jahr
Abstract
Medical systematic reviews play a vital role in healthcare decision making and policy. However, their production is time-consuming, limiting the availability of high-quality and up-to-date evidence summaries. Recent advancements in LLMs offer the potential to automatically generate literature reviews on demand, addressing this issue. However, LLMs sometimes generate inaccurate (and potentially misleading) texts by hallucination or omission. In healthcare, this can make LLMs unusable at best and dangerous at worst. We conducted 16 interviews with international systematic review experts to characterize the perceived utility and risks of LLMs in the specific context of medical evidence reviews. Experts indicated that LLMs can assist in the writing process by drafting summaries, generating templates, distilling information, and crosschecking information. They also raised concerns regarding confidently composed but inaccurate LLM outputs and other potential downstream harms, including decreased accountability and proliferation of low-quality reviews. Informed by this qualitative analysis, we identify criteria for rigorous evaluation of biomedical LLMs aligned with domain expert views.
Ähnliche Arbeiten
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021 · 85.301 Zit.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 · 82.806 Zit.
The Measurement of Observer Agreement for Categorical Data
1977 · 76.958 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 62.803 Zit.
Measuring inconsistency in meta-analyses
2003 · 61.524 Zit.